• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

A Review on Sustained Release Matrix Tablet of Antihypertensive Drug

    Arvind Raghav, Ashish Singh Chauhan, Dharmendra Kumar, Km. Anjali, Pooja, Hareem Fatima, Mohd Ovaid, Supriya Maity

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 8473-8484

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Now, the daily pharmaceutical industry is focused on developing common oral dosage forms as it becomes essential medical tool. This continuous-release formulation is designed to release the drug at a predetermined rate and keep the plasma drug overflow in a medical window with minimal side effects. The basic idea behind continuous drug delivery is to change the drug's biopharmaceutical, pharmacokinetic, and pharmacodynamics to reduce side effects, provide patient compliance, and treat the disease. Continued discontinuation of drug delivery improved patient compliance due to frequent drug administration, decreased flexibility in consistent drug levels, higher drug use, increased dosage of effective drug dosage, and reduced health care costs with improved treatment and shorter treatment duration. The main goal of the continuous-release forms is the development of drug treatment that has tested the relationship between the benefits and disadvantages of using a constant-release system. This review article contained basic information on the matrix type of the ongoing drug delivery system. Nowadays, there are very few drugs out of research and development, and existing drugs have a problem with resistance due to their unreasonable use, especially in the case of drugs such as antibiotics. Therefore, the mutation is an effective and efficient way to make a particular medication more effective with a slight change in drug delivery. Continuous extraction also provides a promising way to reduce the side effects of the drug by preventing fluctuations in the drug's therapeutic effect on the body. Drug administration through such a system involves controlled dispersal and distribution methods. If not correctly formulated, many medications can release the drug very quickly and may produce the drug's toxic effects orally. This article carries basic information about the structure of the release version and various similar types.
Keywords:
    Sustained release Matrix tablet Oral drug delivery system Antihypertensive drugs
  • PDF (480 K)
  • XML
(2022). A Review on Sustained Release Matrix Tablet of Antihypertensive Drug. European Journal of Molecular & Clinical Medicine, 9(7), 8473-8484.
Arvind Raghav, Ashish Singh Chauhan, Dharmendra Kumar, Km. Anjali, Pooja, Hareem Fatima, Mohd Ovaid, Supriya Maity. "A Review on Sustained Release Matrix Tablet of Antihypertensive Drug". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 8473-8484.
(2022). 'A Review on Sustained Release Matrix Tablet of Antihypertensive Drug', European Journal of Molecular & Clinical Medicine, 9(7), pp. 8473-8484.
A Review on Sustained Release Matrix Tablet of Antihypertensive Drug. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 8473-8484.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 34
  • PDF Download: 21
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus